Welcome to LookChem.com Sign In|Join Free

CAS

  • or

889654-06-2

Post Buying Request

889654-06-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

889654-06-2 Usage

General Description

3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate is a chemical compound with a molecular structure that includes a benzoate group, a methoxy group, and a boron-containing tetramethyl dioxaborolane group. It is often used as a building block in organic synthesis reactions and as a reagent in chemical research. 3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate is known for its stability and versatility, making it popular in various applications such as pharmaceuticals, agrochemicals, and materials science. Its unique structure and properties make it an important tool for creating new chemical compounds and investigating their potential uses.

Check Digit Verification of cas no

The CAS Registry Mumber 889654-06-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,9,6,5 and 4 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 889654-06:
(8*8)+(7*8)+(6*9)+(5*6)+(4*5)+(3*4)+(2*0)+(1*6)=242
242 % 10 = 2
So 889654-06-2 is a valid CAS Registry Number.

889654-06-2Relevant articles and documents

Synthesis of diverse 3-azido-5-(azidomethyl)benzene derivatives via formal C-H azidation and functional group-selective transformations

Nishiyama, Yoshitake,Misawa, Yoshihiro,Hazama, Yuki,Oya, Kazuhiro,Yoshida, Suguru,Hosoya, Takamitsu

, p. 1053 - 1072 (2019/07/31)

3-Azido-5-(azidomethyl)benzene derivatives are useful compounds for preparing diverse bistriazole compounds and photoaffinity probes for target identification of bioactive compounds. To more easily synthesize a diverse range of diazido compounds, a facile

NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

-

Paragraph 0802; 0803; 0813, (2016/07/27)

The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.

Targeting the heat shock protein 90 dimer with dimeric inhibitors

Kusuma, Bhaskar Reddy,Peterson, Laura B.,Zhao, Huiping,Vielhauer, George,Holzbeierlein, Jeffrey,Blagg, Brian S. J.

, p. 6234 - 6253 (2011/10/31)

The design, synthesis, and biological evaluation of conformationally constrained coumermycin A1 analogues are reported. Compounds were evaluated against both breast cancer (SKBr3 and MCF7) and prostate cancer (PC3 mm2, A549, and HT29) cell lines. Non-noviosylated coumermycin A1 analogues that manifest potent antiproliferative activity resulting from Hsp90 inhibition are provided, wherein replacement of the stereochemically complex noviose sugar with readily available piperidine rings resulted in ü100 fold increase in antiproliferative activities as compared to coumermycin A1, producing small molecule Hsp90 inhibitors that exhibit nanomolar activities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 889654-06-2